EnteroMedics

homesitemapcontact us

   search

 

   
   
   
   

EnteroMedics is the developer of vBloc® neurometabolic therapy, delivered by a pacemaker-like device called the Maestro® Rechargeable System, a first-in-class weight loss treatment for obesity and obesity related risk factors, such as high blood pressure or high cholesterol levels. vBloc® Therapy is a non-anatomy altering or restricting, reversible therapy that allows patients to safely lose weight by helping patients feel less hungry, reduce the amount of food eaten at a meal, and feel full longer in between meals.

NASDAQ: ETRM

 
 

more news >
 

   
   
   


EnteroMedics has significant experience with vBloc Therapy; more than 600 patients have been implanted with the Maestro System to date, some out to five years.

learn more >

 


At EnteroMedics, partnerships are viewed as an excellent approach for achieving our business objectives, and we are interested in hearing from you.

learn more >

 

 


learn more >